Navellier & Associates Inc Abbott Laboratories Transaction History
Navellier & Associates Inc
- $705 Million
- Q3 2024
A detailed history of Navellier & Associates Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Navellier & Associates Inc holds 6,860 shares of ABT stock, worth $778,198. This represents 0.11% of its overall portfolio holdings.
Number of Shares
6,860
Previous 6,860
-0.0%
Holding current value
$778,198
Previous $712,000
9.83%
% of portfolio
0.11%
Previous 0.08%
Shares
3 transactions
Others Institutions Holding ABT
# of Institutions
3,186Shares Held
1.3BCall Options Held
8.74MPut Options Held
8.08M-
Vanguard Group Inc Valley Forge, PA168MShares$19 Billion0.35% of portfolio
-
Black Rock Inc. New York, NY131MShares$14.9 Billion0.31% of portfolio
-
State Street Corp Boston, MA76.7MShares$8.7 Billion0.36% of portfolio
-
Capital International Investors Los Angeles, CA65.7MShares$7.46 Billion1.49% of portfolio
-
Capital Research Global Investors Los Angeles, CA53.3MShares$6.05 Billion1.31% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $199B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...